Cetuximab Bulk Active from Canada

Cetuximab targets EGFR for colorectal cancer treatment as monoclonal antibody. Unmixed form under HTS 3002.13.0090 as per immunological product notes. Biotechnologically produced.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

EGFR specificity assays required for validation

Avoid animal facility imports without vet clearance

pH stability critical for classification

Cetuximab Bulk Active from Canada — Import Duty Rate | HTS 3002.13.00.90